Wordt geladen...
Treatment options in non-muscle-invasive bladder cancer after BCG failure
Bladder cancer is the ninth-most prevalent cancer worldwide. Most patients with urothelial cell carcinoma of the bladder present with non-muscle-invasive disease and are treated with bacillus Calmette-Guérin (BCG) intravesical therapy. Many of these patients experience disease recurrence after BCG f...
Bewaard in:
Gepubliceerd in: | Indian J Urol |
---|---|
Hoofdauteurs: | , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Medknow Publications & Media Pvt Ltd
2015
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4626915/ https://ncbi.nlm.nih.gov/pubmed/26604442 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0970-1591.166475 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|